Abdulwhhab Abu Alamrain

Abdulwhhab Abu Alamrain

Auto-generated profile, based on publicly available information

Abdulwhhab Abu Alamrain

Al-Quds University

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2022 in The Lancet Global Health
Verified
Journal Article
Open access
CSCatherine A Shaw
Catherine A Shaw
RPRiinu Pius
Riinu Pius
TDThomas M Drake
Thomas M Drake
LNLisa Norman
Lisa Norman
AAAdesoji O Ademuyiwa
Adesoji O Ademuyiwa
JLJean Wilguens Lartigue
Jean Wilguens Lartigue
Early death after cancer surgery is higher in low-income and middle-income countries (LMICs) compared with in high-income countries, yet the impact of facility characteristics on early postoperative outcomes is unknown. The aim of this study was to examine the association between hospital infrastructure, resource availability, and processes on early outcomes after cancer surgery worldwide. A multimethods analysis was performed as part of the GlobalSurg 3 study—a multicentre, international, prospective cohort study of patients who had surgery for breast, colorectal, or gastric cancer. The primary outcomes were 30-day mortality and 30-day major complication rates. Potentially beneficial hospital facilities were identified by variable selection to select those associated with 30-day mortality. Adjusted outcomes were determined using generalised estimating equations to account for patient characteristics and country-income group, with population stratification by hospital. Between April 1, 2018, and April 23, 2019, facility-level data were collected for 9685 patients across 238 hospitals in 66 countries (91 hospitals in 20 high-income countries; 57 hospitals in 19 upper-middle-income countries; and 90 hospitals in 27 low-income to lower-middle-income countries). The availability of five hospital facilities was inversely associated with mortality: ultrasound, CT scanner, critical care unit, opioid analgesia, and oncologist. After adjustment for case-mix and country income group, hospitals with three or fewer of these facilities (62 hospitals, 1294 patients) had higher mortality compared with those with four or five (adjusted odds ratio [OR] 3·85 [95% CI 2·58–5·75]; p<0·0001), with excess mortality predominantly explained by a limited capacity to rescue following the development of major complications (63·0% vs 82·7%; OR 0·35 [0·23–0·53]; p<0·0001). Across LMICs, improvements in hospital facilities would prevent one to three deaths for every 100 patients undergoing surgery for cancer. Hospitals with higher levels of infrastructure and resources have better outcomes after cancer surgery, independent of country income. Without urgent strengthening of hospital infrastructure and resources, the reductions in cancer-associated mortality associated with improved access will not be realised. National Institute for Health and Care Research.

22 May 2025 in The Lancet Healthy Longevity
Verified
Journal Article
Open access
BIBilal Irfan
Bilal Irfan
AAAbdulwhhab Abu Alamrain
Abdulwhhab Abu Alamrain
ASAbdallah Abu Shammala
Abdallah Abu Shammala

5 January 2024 in European Journal of Medical Research
Verified
Journal Article
Open access
PDF file
FZFarida Zakariya
Farida Zakariya
FSFatma K. Salem
Fatma K. Salem
AAAbdulwhhab Abu Alamrain
Abdulwhhab Abu Alamrain
VSVivek Sanker
Vivek Sanker
ZAZainab G. Abdelazeem
Zainab G. Abdelazeem
WAWireko Andrew Awuah
Wireko Andrew Awuah
Using the particular nature of melanoma mutanomes to develop medicines that activate the immune system against specific mutations is a game changer in immunotherapy individualisation. It offers a viable solution to the recent rise in resistance to accessible immunotherapy alternatives, with some patients demonstrating innate resistance to these drugs despite past sensitisation to these agents. However, various obstacles stand in the way of this method, most notably the practicality of sequencing each patient's mutanome, selecting immunotherapy targets, and manufacturing specific medications on a large scale. With the robustness and advancement in research techniques, artificial intelligence (AI) is a potential tool that can help refine the mutanome-based immunotherapy for melanoma. Mutanome-based techniques are being employed in the development of immune-stimulating vaccines, improving current options such as adoptive cell treatment, and simplifying immunotherapy responses. Although the use of AI in these approaches is limited by data paucity, cost implications, flaws in AI inference capabilities, and the incapacity of AI to apply data to a broad population, its potential for improving immunotherapy is limitless. Thus, in-depth research on how AI might help the individualisation of immunotherapy utilising knowledge of mutanomes is critical, and this should be at the forefront of melanoma management.

24 February 2026 in Medicine, Conflict and Survival
Verified
Journal Article
Closed access
AAAbdulwhhab Abu Alamrain
Abdulwhhab Abu Alamrain
BIBilal Irfan
Bilal Irfan
KIKhansa Irfan
Khansa Irfan
AIAhmad Ibsais
Ahmad Ibsais
MLMaria Leister
Maria Leister
MZMohammed Zughbur
Mohammed Zughbur

10 January 2026 in Injury
Verified
Journal Article
Closed access
HSHosam Shaikhkhalil
Hosam Shaikhkhalil
AAAbdulwhhab Abu Alamrain
Abdulwhhab Abu Alamrain
HTHitham I. Toman
Hitham I. Toman
DMDeema A. Muhaisen
Deema A. Muhaisen
MAMajdi A. Alkhaldi
Majdi A. Alkhaldi
MAMohammed Aladini
Mohammed Aladini

1 April 2025 in Trauma Surgery & Acute Care Open
Verified
Journal Article
Open access
PDF file
HSHosam Shaikhkhalil
Hosam Shaikhkhalil
AAAbdulwahhab Abu Alamrain
Abdulwahhab Abu Alamrain
MMMohammad A M Mattar
Mohammad A M Mattar
EKElinore Kaufman
Elinore Kaufman
MAMohammed Aladini
Mohammed Aladini
A patient presented during a mass casualty event after an airstrike with abdominal injuries from penetrating fragments and the blast wave. The patient was hemodynamically unstable and was transferred to the operating room under wartime triage protocols. Intraoperatively, a grade IV liver injury involving segments IV, V, and VI was controlled by packing. There was a zone I hematoma that was explored, revealing a pancreatic head injury and peri-duodenal hematoma with an intact duodenal wall. A gastric injury was repaired. The patient received five units of packed red blood cells and four units of fresh frozen plasma. The fascia and skin were closed with plans for a second-look laparotomy.